JO
LKFT

John Overdeck’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

John Overdeck’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.45M Buy
81,749
+55,889
+216% +$1.59M ﹤0.01% 2813
2026
Q1 		$776K Buy
25,860
+9,500
+58% +$315K ﹤0.01% 3440
2025
Q4 		$535K Sell
16,360
-6,099
-27% -$197K ﹤0.01% 3266
2025
Q3 		$778K Buy
22,459
+800
+4% +$25.6K ﹤0.01% 2741
2025
Q2 		$606K Sell
21,659
-27,502
-56% -$737K ﹤0.01% 2500
2025
Q1 		$1.23M Buy
+49,161
New +$1.24M ﹤0.01% 2050
2024
Q2 		– Sell
-22,714
Closed -$731K – 3144
2024
Q1 		$731K Buy
22,714
+12,588
+124% +$468K ﹤0.01% 2140
2023
Q4 		$412K Sell
10,126
-2,074
-17% -$76.3K ﹤0.01% 2558
2023
Q3 		$422K Sell
12,200
-600
-5% -$23.4K ﹤0.01% 2348
2023
Q2 		$520K Buy
12,800
+900
+8% +$36.7K ﹤0.01% 2313
2023
Q1 		$460K Buy
+11,900
New +$489K ﹤0.01% 2242

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

John Overdeck's LKFT Position: Q2 2026 in Review

John Overdeck increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 216% in Q2 2026, buying an estimated $1.59M and bringing the position to 81,749 shares worth $2.45M. The position accounts for ﹤0.01% of the portfolio, ranked #2813.

John Overdeck first reported a position in LKFT in Q1 2023 and has held it in 11 quarters since. 77 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • John Overdeck held 81,749 shares of Lakefront Biotherapeutics American Depositary Shares worth $2.45M as of Q2 2026.
  • John Overdeck bought 55,889 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $1.59M.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #2813 holding.
  • John Overdeck first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2023 and has held it in 11 quarters since.
  • 77 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.